![Xiao Ying Meng](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xiao Ying Meng
Direktor/Vorstandsmitglied bei BMC MEDICAL CO., LTD.
Aktive Positionen von Xiao Ying Meng
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BMC MEDICAL CO., LTD. | Direktor/Vorstandsmitglied | 01.12.2019 | - |
TYK Medicines, Inc.
![]() TYK Medicines, Inc. Pharmaceuticals: MajorHealth Technology TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the business of research, development and commercialization of pharmaceutical products and differentiated targeted therapies to address unmet medical needs in cancer treatment. The company was founded by Wu Yusheng on November 2, 2017 and is headquartered in Huzhou, China. | Direktor/Vorstandsmitglied | 01.01.2021 | - |
Karriereverlauf von Xiao Ying Meng
Ehemalige bekannte Positionen von Xiao Ying Meng
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CHENGDU BRIGHT EYE HOSPITAL CO., LTD. | Direktor/Vorstandsmitglied | 28.12.2018 | 10.10.2022 |
Ausbildung von Xiao Ying Meng
Nanjing University | Undergraduate Degree |
The Pennsylvania State University | Doctorate Degree |
Statistik
International
China | 5 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 3 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 3 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
CHENGDU BRIGHT EYE HOSPITAL CO., LTD. | Health Services |
BMC MEDICAL CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
TYK Medicines, Inc.
![]() TYK Medicines, Inc. Pharmaceuticals: MajorHealth Technology TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the business of research, development and commercialization of pharmaceutical products and differentiated targeted therapies to address unmet medical needs in cancer treatment. The company was founded by Wu Yusheng on November 2, 2017 and is headquartered in Huzhou, China. | Health Technology |
- Börse
- Insiders
- Xiao Ying Meng
- Erfahrung